Literature DB >> 4593518

Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia.

J Gerlach, N Reisby, A Randrup.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4593518     DOI: 10.1007/bf00421217

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  44 in total

1.  Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.

Authors:  H A McClelland
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

2.  Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.

Authors:  J Gerlach; H Simmelsgaard
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

3.  Effect of ceruletide on tardive dyskinesia: a pilot study of quantitative computer analyses on electromyogram and microvibration.

Authors:  T Nishikawa; M Tanaka; A Tsuda; H Kuwahara; I Koga; Y Uchida
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Striatal dopamine D2 receptors in tardive dyskinesia: PET study.

Authors:  J Blin; J C Baron; H Cambon; A M Bonnet; B Dubois; C Loc'h; B Mazière; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-11       Impact factor: 10.154

5.  Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.

Authors:  Y Hatta; S Hatta; T Saito
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 6.  Management of tardive dyskinesia: current update.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

7.  Oral dyskinesia in rats following brain lesions and neuroleptic drug administration.

Authors:  L M Gunne; J Growdon; B Glaeser
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.

Authors:  U K Rinne; E Birket-Smith; E Dupont; E Hansen; M Hyyppä; R Marttila; B Mikkelsen; H Pakkenberg; J Presthus
Journal:  J Neurol       Date:  1975-12-02       Impact factor: 4.849

9.  [Deanol in tardive dyskinesia: a double-blind study (author's transl)].

Authors:  S Bockenheimer; G Lucius
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-09-17

10.  Benzodiazepines in psychotic States.

Authors:  J Ananth; O Solano
Journal:  Indian J Psychiatry       Date:  1993-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.